Evaluation of Safety and Parameters of Application Technique

Novo Nordisk A/S4,819 enrolled

Overview

This study is conducted in Europe. The aim of the study is to monitor patients changing therapy from syringe to insulin delivery system as prescribed by the treating physician in Slovakia.

Study Type

OBSERVATIONAL

Enrollment

4,819

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems

Interventions

No treatment givenOTHER

Collection of data about patients with type 1 diabetes or type 2 diabetes treated with insulin changing their insulin administration from syringe to a insulin delivery system based on completion of questionaire

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Diabetes mellitus (type 1 or type 2) * Treated with insulin

Locations (1)

Novo Nordisk Investigational Site

Bratislava, Slovakia

Outcomes

Primary Outcomes

Number of insulin applications (punctures)

Reasons leading to change of the therapy

Patient satisfaction with NovoPen® 4 insulin delivery system

Secondary Outcomes

Adverse reactions

Hypoglycaemia

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.